CIK 0001022899
- Non-accelerated filer
- Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061390025
- Phone
- +1 212-994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- 4 Open-market buy See Remarks bought 60,211 shares at $1.25 ($75,264)
- 4 Grant or award Director acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 45,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 140,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 500,000 shares (grant or award)
- 4 Grant or award Director acquired 45,000 shares (grant or award)
- 4 Grant or award Director acquired 45,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 7 · 137 filings